Tag: Investments

Chiesi Group Plans to Invest €350m to Reduce Carbon Footprint of pMDI Inhalers

investments
Chiesi, the international research-focused healthcare Group (Chiesi Group), announces at the United Nations Climate Change Conference (COP25) its plan to bring to the market by the end of 2025 a break...

BioCity to Invest in Self-Care Therapeutics Movement

Life-science incubator and business collective, BioCity, has invested in Maxwellia, a company based at Alderley Park in the United Kingdom that is driving industry movement towards self-care therapeut...

Slowing of Chinese Investments into U.S. Biotechs Likely to Get Worse

investment
Chinese VCs say the slowing of investments into U.S. biotechs is likely to get worse before it gets better. In addition to continued CFIUS concerns and the ongoing trade war, capital inflows to Chines...

UK to Invest £16m in ‘Life-Saving’ Medical Advances

The British government has announced the decision to invest around £16 million in various ‘life-saving’ medical advances, including improved diagnosis and treatment for cancer and heart disease. 13...

Pharma Invests £377m in UK R&D Collaborations, New ABPI Figures Showed

New figures published by the ABPI show that pharma invests £377m in UK R&D collaborations, working with healthcare professionals and organisations to improve care for NHS patients. The data pub...

$150 million Sino-Singapore Healthcare Fund Established by Novena Global, Sinopharm, and Cedarlake

investments
Singapore-based healthcare firm Novena Global Lifecare, together with Chinese healthcare private equity firm Sinopharm Capital and investor Cedarlake Capital has raised a US$150 million healthcare-foc...

OJSC Pharmstandard-Leksredstva Plans to Draw $7m for Modernization in 2019

UfaVita Factory
OJSC Pharmstandard-Leksredstva, Pharmstandard’s structure based in Kursk, plans to draw 500 million rubles in 2019 for modernization. The company plans to start manufacturing 15 new pharmaceutical ...

Allergan to Invest €65M in Ireland

allergan
Pharmaceutical giants Allergan have announced the creation of 63 new jobs as part of a €65 million investment in the west of Ireland. Global life-science company, Allergan, headquartered in Ireland...

Consortium of Investors to Support the Creation of Leading Russian Pharmaceutical Holding

A consortium of investors including the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), the Russia-China Investment Fund (RCIF, established by RDIF and China Investment Corporat...

Fujifilm Invests $90m to Expand its FDB

Fujifilm Corporation announced plans to invest approximately $90 million to expand its bio contract development and manufacturing organization (CDMO) business— Fujifilm Diosynth Biotechnologies (FDB)....

PCI to Invest $20m in Biotech Technologies Development

Demand for Biotech packaging drives significant PCI investment at multiple locations world wide. PCI is pleased to announce a momentous investment in support of biologic medicines and advanced inje...

Catalent to Expand Biologics Capabilities

Catalent, a provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has started a $200m capital investment to expand biologics capacity ...

AGC boosts its biopharmaceutical production capacity

biotechnology
AGC, a world-leading manufacturer of glass, chemicals and high-tech materials, has announced a major expansion of AGC Biologics, a CDMO subsidiary of the company. At AGC Biologics’ Seattle (USA) si...

Vedanta Raised $27m to Investigate Microbiome-Derived Therapies

US-based Vedanta Biosciences has raised $27 million in a Series C financing to investigate microbiome-derived therapies for several indications, including cancer and food allergy. Investors include...

Fuji Pharma makes $50 million investment in Alvotech

biosimilars
Alvotech (Iceland), a biopharmaceutical company announced that Fuji Pharma (Japan) has acquired a 4.2% stake in the business for approximately $50 million.

Dutch biotech signs drug development agreement with Novo Nordisk

lab
Staten Biotechnology and Novo Nordisk have entered into a collaboration and exclusive option agreement to develop novel therapeutics for the treatment of hypertriglyceridaemia.